These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4954023)

  • 1. Effect of some drugs on hexosamine synthesis in Ehrlich ascites carcinoma cells and on hyaluronic acid content in the ascitic fluid.
    Hano K; Nishino Y
    Gan; 1965 Aug; 56(4):367-75. PubMed ID: 4954023
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of various carcinostatic agents on acridine orange uptake by Ehrlich ascites carcinoma cells.
    Hano K; Iwata H; Morita S
    Gan; 1966 Feb; 57(1):19-26. PubMed ID: 4959535
    [No Abstract]   [Full Text] [Related]  

  • 3. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents].
    Koga H
    Kumamoto Igakkai Zasshi; 1971 Feb; 45(2):169-99. PubMed ID: 5109085
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of carcinostatic agents on antitumor activity of sensitized lymphoid cells.
    Hashimoto Y; Sudo H; Ishidate M
    Gan; 1967 Feb; 58(1):31-44. PubMed ID: 4963865
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of a moderate staphylococcal phage by means of antineoplastic agents].
    Smolianskaia AZ; Leĭkina FI
    Antibiotiki; 1970 Jun; 15(6):514-9. PubMed ID: 4195833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
    Schmid I; Karzel K
    Arzneimittelforschung; 1968 Dec; 18(12):1498-500. PubMed ID: 4976453
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):385-402. PubMed ID: 4954025
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase of glycogen and oligosaccharide contents in ascites tumor cells under the influence of alkylating agents.
    Tashiro T; Sakurai Y
    Gan; 1969 Aug; 60(4):465-8. PubMed ID: 4310237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histochemical and biochemical studies on the effects of anticancer agents on glycogen metabolism in AH13 ascites hepatoma].
    Sudo I
    Kumamoto Igakkai Zasshi; 1969 Apr; 43(4):277-96. PubMed ID: 4308494
    [No Abstract]   [Full Text] [Related]  

  • 11. PHARMACOLOGICAL STUDIES ON THE METABOLISM OF MUCOPOLYSACCHARIDES IN TUMOR CELLS.
    HANO K; NISHINO Y
    Gan; 1965 Feb; 56():49-58. PubMed ID: 14326033
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro test for sensitivity of tumor to carcinostatic agents.
    Kondo T; Imamura T; Ichihashi H
    Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thymidine transport and its incorporation into the cellular DNA of Ehrlich ascites cancer and Zajdela's ascitic hepatoma in the presence of thiophosphamide and thiophosphamide-modified DNA].
    Patskovskiĭ IuV; Voloshchuk TP
    Eksp Onkol; 1989; 11(4):37-41. PubMed ID: 2503349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of antineoplastic agents on the activity and molecular heterogeneity of lysosomal hydrolases in Ehrlich ascites tumor].
    Filov VA; Tret'iakov AV; Riazanov EM
    Dokl Akad Nauk SSSR; 1974 Aug; 217(4):961-4. PubMed ID: 4211407
    [No Abstract]   [Full Text] [Related]  

  • 15. Cloturin: effect on energy-producing processes in Ehrlich ascites and P388 murine leukaemia cells.
    Miko M; Krepelka J; Melka M
    Cell Biochem Funct; 1992 Jun; 10(2):115-22. PubMed ID: 1628380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On various points of application of trenimon and mitomen in nucleic acid metabolism of tumor cells. (Studies with 3H-thymidine, 3H-cytidine and 32P)].
    Liss E; Palme G; Oeff K
    Nucl Med (Stuttg); 1965; 2():55-61. PubMed ID: 5888980
    [No Abstract]   [Full Text] [Related]  

  • 17. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
    DIPAOLO JA
    Proc Soc Exp Biol Med; 1963 Nov; 114():384-7. PubMed ID: 14101198
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
    Papoian SA; Kumkumadzhian VA
    Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of mechlorethamine and cyclophosphamide on the nicotinamide-adenine dinucleotide glycohydrolase activity in Ehrlich ascites cells and L1210 leukemia cells.
    Fraser I
    Proc West Pharmacol Soc; 1965; 8():61-3. PubMed ID: 4285800
    [No Abstract]   [Full Text] [Related]  

  • 20. Hexosamine containing substances in cancer. VI. Distribution of hexosamine in subcellular fractions of normal mouse liver and Ehrlich ascitic carcinoma.
    Kolárová M; Brada Z; Pechan Z
    Neoplasma; 1965; 12(4):379-83. PubMed ID: 5854409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.